LexDanaLexDanabeta
Inventor

Szu-Liang LAI

Inventor
TW

Overview

3→
Patents
2024–2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes27%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
C07KPeptides27%
C12NMicroorganisms or enzymes18%
PatentTitleYear
12,187,806Anti-CD73 antibodies and use thereof202512,091,454Humanized anti-human neurotensin receptor 1 antibodies and their uses202412,043,668Anti-human CSF-1R antibody and uses thereof2024

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2024–2025Patents assigned to DEV CT BIOTECHNOLOGY (3)· patent assignee history
2024Patents assigned to NATIONAL HEALTH RES INST (1)· patent assignee history
2024–2025Based in TW· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
DEV CT BIOTECHNOLOGY32024–2025
NATIONAL HEALTH RES INST12024
Locations
LocationPatentsSpan
TW32024–2025